Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Reader Login
Home Print this page Email this page
Users Online: 72


Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2006| September-December  | Volume 3 | Issue 3  
    Online since December 7, 2011

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
ORIGINAL ARTICLE
Dehydroepiandrosterone supplementation in hypothyroidism
S Kalra, B Kalra, G Nanda
September-December 2006, 3(3):71-75
Dehydroepiandrosterone sulphate (DHEA-S) deficiency is a common but under diagnosed cause of asthenia. The aim of the study was to assess the frequency of DHEA-S deficiency in hypothyroidism, its clinical correlates, and the effect of DHEA supplementation in these patients. consecutive well-controlled hypothyroid patients, complaining 'asthenia' for ii month were assessed for DHEA-S levels. Patients with low DHEA-S or with levels in the lower quartile of normal were supplemented with oral DHEA. Monthly follow-up was done to assess biochemical and clinical results, aiming for a DHEA-S level in the upper half of normal range. out of 72 patients had DHEA-S deficiency. The average dose of DHEA required to correct DHEA-S levels at 6 months was 18.75 ± 6.30mg/day. 82.60% patients reported marked improvement while 8.69% felt fair improvement in their symptoms with DHEA supplementation. There was no change in thyroxine dose requirement. A significant number of patients felt improvement in Libido (62.50%) and erectile function (25.0%). 8.71% dropped out due to various side effects. To conclude, DHEA-S deficiency is an easily treatable cause of asthenia in hypothyroidism.
[ABSTRACT]   Full text not available  [PDF]
  619 189 -
REVIEW ARTICLE
Screening for neonatal hypothyroidism : A review
AM Samuel
September-December 2006, 3(3):76-88
This is an in-depth article focusing on the controversies that surround the issue of neonatal screening for hypothyroidism
[ABSTRACT]   Full text not available  [PDF]
  484 149 -
EDITORIAL
What is the optimal thyroid hormone replacement and how far are we from individualising thyroid hormone therapy?
P Saravanan
September-December 2006, 3(3):67-70
Full text not available  [PDF]
  304 152 -
OTHERS
Cretinism : A 25 - year follow up
Ratan KR Kotokey
September-December 2006, 3(3):89-91
Full text not available  [PDF]
  314 136 -
EDITORIALS
Reply to letter by Dr. Kumaresan
A Naveen, TK Sabeer, A Bhattacharyya
September-December 2006, 3(3):94-94
Full text not available  [PDF]
  288 134 -
Letter to Editor
K Kumaresan
September-December 2006, 3(3):93-93
Full text not available  [PDF]
  235 129 -
OTHERS
Thyroid Watch
MG Pillai
September-December 2006, 3(3):92-92
Full text not available  [PDF]
  219 121 -
Feedback
Subscribe